These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33066680)

  • 1. Overcoming the Solubility Barrier of Ibuprofen by the Rational Process Design of a Nanocrystal Formulation.
    Ouranidis A; Gkampelis N; Vardaka E; Karagianni A; Tsiptsios D; Nikolakakis I; Kachrimanis K
    Pharmaceutics; 2020 Oct; 12(10):. PubMed ID: 33066680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanocrystal formulations of mebendazole employing quality by design and molecular level insights by atomistic simulations.
    Vardaka E; Kachrimanis K
    Drug Dev Ind Pharm; 2024 Aug; 50(8):735-749. PubMed ID: 39212605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of agomelatine nanocomposite formulations by wet media milling.
    Vardaka E; Andreas O; Nikolakakis I; Kachrimanis K
    Eur J Pharm Sci; 2021 Nov; 166():105979. PubMed ID: 34425232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of formulation and process parameters for the production of carvedilol nanosuspension by wet media milling.
    Medarević D; Djuriš J; Ibrić S; Mitrić M; Kachrimanis K
    Int J Pharm; 2018 Apr; 540(1-2):150-161. PubMed ID: 29438724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of Formulation and Process Parameters of Wet Media Milling to Develop Etodolac Nanosuspensions.
    Karakucuk A; Celebi N
    Pharm Res; 2020 May; 37(6):111. PubMed ID: 32476048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into the Formation of Glimepiride Nanocrystals by Wet Media Milling.
    Medarević D; Ibrić S; Vardaka E; Mitrić M; Nikolakakis I; Kachrimanis K
    Pharmaceutics; 2020 Jan; 12(1):. PubMed ID: 31936609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes.
    Patel PJ; Gajera BY; Dave RH
    Drug Dev Ind Pharm; 2018 Dec; 44(12):1942-1952. PubMed ID: 30027778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of aprepitant nanocrystals by wet media milling and subsequent solidification.
    Toziopoulou F; Malamatari M; Nikolakakis I; Kachrimanis K
    Int J Pharm; 2017 Nov; 533(2):324-334. PubMed ID: 28257885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Particle Size Tailoring of Quercetin Nanosuspensions by Wet Media Milling Technique: A Study on Processing and Formulation Parameters.
    Cheshmehnoor P; Bolourchian N; Abdollahizad E; Derakhshi A; Dadashzadeh S; Haeri A
    Iran J Pharm Res; 2022 Dec; 21(1):e130626. PubMed ID: 36915402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design Space and QbD Approach for Production of Drug Nanocrystals by Wet Media Milling Techniques.
    Peltonen L
    Pharmaceutics; 2018 Jul; 10(3):. PubMed ID: 30044395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermal flurbiprofen nanosuspensions: Optimization with design of experiment approach and in vitro evaluation.
    Oktay AN; Karakucuk A; Ilbasmis-Tamer S; Celebi N
    Eur J Pharm Sci; 2018 Sep; 122():254-263. PubMed ID: 29981401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the influence factors and improvement strategies of drug polymorphic transformation combined kinetic and thermodynamic perspectives during the formation of nanosuspensions.
    Meng T; Qiao F; Ma S; Gao T; Li L; Hou Y; Yang J
    Drug Dev Ind Pharm; 2021 Dec; 47(12):1867-1880. PubMed ID: 35362347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solidification of hesperidin nanosuspension by spray drying optimized by design of experiment (DoE).
    Wei Q; Keck CM; Müller RH
    Drug Dev Ind Pharm; 2018 Jan; 44(1):1-12. PubMed ID: 28967287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Itraconazole Nanosuspensions via Dual Centrifugation Media Milling: Impact of Formulation and Process Parameters on Particle Size and Solid-State Conversion as Well as Storage Stability.
    Willmann AC; Berkenfeld K; Faber T; Wachtel H; Boeck G; Wagner KG
    Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 35893783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and solidification of redispersible nanosuspensions.
    Zhang X; Guan J; Ni R; Li LC; Mao S
    J Pharm Sci; 2014 Jul; 103(7):2166-2176. PubMed ID: 24840928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Screening Study for the Selection of Proper Stabilizers to Produce Physically Stable Canagliflozin Nanosuspension by Wet Milling Method.
    Pirincci Tok Y; Mesut B; Güngör S; Sarıkaya AO; Aldeniz EE; Dude U; Özsoy Y
    Bioengineering (Basel); 2023 Aug; 10(8):. PubMed ID: 37627812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active freeze drying for production of nanocrystal-based powder: A pilot study.
    Touzet A; Pfefferlé F; der Wel PV; Lamprecht A; Pellequer Y
    Int J Pharm; 2018 Jan; 536(1):222-230. PubMed ID: 29175644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality by design approach to understand the process of nanosuspension preparation.
    Verma S; Lan Y; Gokhale R; Burgess DJ
    Int J Pharm; 2009 Jul; 377(1-2):185-98. PubMed ID: 19446617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-Alpha-tocopherol acid polyethylene glycol 1000 succinate, an effective stabilizer during solidification transformation of baicalin nanosuspensions.
    Yue PF; Wan J; Wang Y; Li Y; Ma YQ; Yang M; Hu PY; Yuan HL; Wang CH
    Int J Pharm; 2013 Feb; 443(1-2):279-87. PubMed ID: 23291447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanocrystal-based drug delivery system of risperidone: lyophilization and characterization.
    Gol D; Thakkar S; Misra M
    Drug Dev Ind Pharm; 2018 Sep; 44(9):1458-1466. PubMed ID: 29619857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.